DxMedical Cloud™
Technology for overwhelmingly high-speed detection from all over the world.
We use our unique algorithm to deliver the latest technology and product information from around the world in real time.
Explore the future of healthcare with carefully selected information.
Explore the future of healthcare with carefully selected information.
Login
How We Help You To Empower Your Business
POINT 1.
Quickly Deliver Technical Information
We deliver what you seek quickly and in a short time from technical information from all over the world
POINT 2.
Briefly to the Point
A wealth of detailed features makes it easy to understand the main points
POINT 3.
Help with Growth Strategies
The report is also packed with analytical information from the perspective of growth and long-term strategies for business use
Catch Up on the Latest Information
from Around the World
from Around the World
In today's world, where the world is networked by advances in information technology and numerous technologies are evolving at an astonishing speed, it is extremely difficult to manually collect and manage the vast amount of information from all over the world.
DxMedical Cloud™ collects and analyzes professional information from around the world and uses proprietary algorithms to quickly and accurately deliver the information you seek and the best information for you.
search
Quick search in Japanese
You can quickly search for information published in various languages around the world in Japanese. Get the information you need from the vast amount of information available worldwide without having to worry about language barriers.
emergency
Recommendations for You
DxMedical Cloud's proprietary algorithms predict the best information based on your interests and preferences and deliver it to you daily. Stay one step ahead of the curve without the hassle of searching, maximizing your daily information gathering.
Fuzzy Search
In addition to word matching, the search by similar and related keywords delivers news that is often missed due to paraphrasing and shaky spelling.
Japanese Localization
By providing titles and summaries of information from around the world in Japanese, it streamlines the process of “finding” the information you want from search results.
Academic Search
For researchers and professionals, you can search and browse more specialized information, such as articles submitted to journals by universities and research institutes.
More features to enhance your team's productivity
Bookmark
Instantly save and manage information that you like or want to look at later because you don't have time, with the bookmark function. You can access the information you need without hassle, saving you a great deal of time and effort.
Note Editor
Simple and intuitive operation allows you to quickly consolidate all information into a notebook and organize information efficiently. It can be used as a powerful tool for effective information sharing.
Information sharing
A wide range of information sharing tools are available, including chat and note sharing functions. We support information sharing with your team in all situations, from casual information sharing to organizing information in teams.
Collaboration
Provides task management functions specifically designed to make information gathering and sharing more efficient. In addition to regular task management functions, this useful tool supports information gathering and sharing, improving the productivity of the entire team.
DigitalMedical Open Innovation
BrainEnergy produce DigitalMedical open
innovation from Tokyo, where you can experience the intersection of cool and passionate design and
technology.
Transform Your Business With Cloud
Looking for the Future of Health Care
OUR TECHNOLOGY HELPS YOUR BUSINESS
Our technology will help your business
Technology
Lactobacillus KB-1 Alleviates PMS Depression and Lethargy—Femtech Effect Demonstrated, Joint Patent Filed
PR TIMES (March 27, 2026) reported that LABioTech, a Hokkaido University-certified startup, and Cosmo Bio filed a joint patent for a novel application of their proprietary lactic acid bacteria strain Pediococcus sp. KB-1, after confirming its effect on alleviating PMS (premenstrual syndrome) symptoms. With 70–80% of Japanese women experiencing PMS symptoms and approximately 5.3% suffering severe enough symptoms to impact daily activities, demand for non-pharmacological approaches is rising. The KB-1 strain, isolated from Hokkaido turnips, possesses immune-stimulating, anti-allergic, and gastric acid resistance properties. In a clinical trial (12 women aged 20–49 with PMS symptoms, 1 month of live bacteria capsule consumption), significant improvements were observed in scores for depression/low mood, loss of interest, lethargy, and feeling overwhelmed—primarily psychological symptoms. Reports of direct oral consumption of Pediococcus genus bacteria improving PMS symptoms are described as rare worldwide. The proposed mechanism: KB-1 metabolizes soy isoflavones to the more bioavailable aglycone form, potentially enabling estrogen-like effects. Future plans include functional food labeling and joint development of PMS/PMDD-targeted supplements.
Microbes That 'Disarm' Peanut Allergy Proteins Discovered in Mouth And Gut
A research team led by scientists from the Autonomous University of Madrid and McMaster University has identified two bacteria—Rothia and Staphylococcus—naturally present in human saliva and the small intestine that can break down the peanut proteins Ara h 1 and Ara h 2, which trigger life-threatening anaphylaxis in allergy sufferers. The findings were published in Cell Host & Microbe. In a clinical study involving 19 children aged 1–14 with peanut allergies enrolled in oral immunotherapy, saliva samples were analyzed to profile each child's oral microbiome prior to treatment. Patients with higher abundances of peanut-protein-degrading bacteria—particularly from the Micrococcales order, including Rothia and Micrococcus—showed greater peanut tolerance and less severe allergic responses, while those with lower tolerance had fewer such microbes. Mouse experiments confirmed that deliberately boosting Rothia levels significantly reduced anaphylactic reactions. The researchers suggest that the oral microbiome could serve as a predictive marker of peanut reactivity threshold and that harnessing bacterial allergen-degrading capabilities holds therapeutic potential for managing food allergies—potentially through probiotics. However, the human findings remain observational, and further clinical testing is needed before such approaches can be considered safe or effective treatments.
Self-powered vibration sensor for wearable health care and voice detection
A new self-powered wearable vibration sensor, composed of densely packed capacitor arrays, has been developed. This sensor requires no external power, maintains stable electrical performance on the skin, and can detect vibrations across a wide frequency range. It can capture subtle physiological vibrations from breathing, speaking, and chest expansion, offering promising applications in personalized healthcare monitoring and voice-operated devices.
Nanosensor Technology Using Single-Walled Carbon Nanotubes Expected Applications in Enzyme Evaluation and Screening
Zymosense is a company developing new nanobiosensing technology for fast and simple enzyme activity measurement. Its core Nanoassay™ platform is based on nanosensor technology using single-walled carbon nanotubes (SWCNTs), detecting changes in near-infrared (NIR) emission accompanying enzyme reactions in real time. A key feature is its elimination of reaction termination and labeled reagents required in conventional enzyme assays, enabling a simple “dilute, add, measure” workflow. Its label-free and highly sensitive measurement capability makes it suitable not only for laboratory use but also for rapid on-site analysis. Applications are anticipated for enzyme evaluation and screening across diverse fields including food, pharmaceuticals, and biofuels.
InventHelp Inventors Develop Protective Cover for Wounds while Showering (SGM-625)
Two inventors from Valpo, Indiana, have created the AQUA SLEEVE, a patent-pending protective cover designed to keep surgical wounds dry during showering. This invention prevents water from reaching the surgical site, eliminating the need for traditional plastic wrap or bags. It offers enhanced protection and peace of mind, featuring a waterproof design that is easy to apply and use. The AQUA SLEEVE is ideal for medical facilities, hospitals, surgical centers, and home use, and is currently available for licensing or sale to manufacturers or marketers through InventHelp.
InventHelp Inventors Develop Protective Cover for Wounds while Showering (SGM-625)
Two inventors from Valpo, Indiana, have created the AQUA SLEEVE, a patent-pending protective cover designed to keep surgical wounds dry during showering. This invention prevents water from reaching the surgical site, eliminating the need for traditional plastic wrap or bags. It offers enhanced protection and peace of mind, featuring a waterproof design that is easy to apply and use. The AQUA SLEEVE is ideal for medical facilities, hospitals, surgical centers, and home use, and is currently available for licensing or sale to manufacturers or marketers through InventHelp.
CRISPR gene editing therapy cuts high cholesterol in half
Suisu no baiotekunorojī kigyō Crispr Therapeutics ga, 15-ri no chiken sankasha o taishō ni rinshō shiken o jisshi. Kenkyū chīmu wa, CRISPR o tsukatte kanzō no shishitsu taisha o ninau `ANGPTL 3' to iu idenshi no hataraki o “teishi” sa seru chiryō o, 1-kai no tenteki de tōyo shita. Kono idenshi ni umaretsuki hen'i ga atte kinō shite inai hito wa LDL koresuterōru ya chūsei shibō ga hikuku, kokoro shikkan no risuku mo chīsai koto ga shira rete ori, akirakana kenkōjō no mondai wa mi rarenai. Konkai no chiken wa, kōshita idenshi no hataraki ga shizen ni tomatte iru jōtai o, jinkō-teki ni saigen suru koto o mokuteki to shite ita.
さらに表示
258
Swiss biotechnology company Crispr Therapeutics conducted a clinical trial on 15 participants. The research team used CRISPR to administer a treatment via a single intravenous infusion that "stops" the activity of a gene called "ANGPTL3," which is responsible for lipid metabolism in the liver. People who are born with a congenital mutation that makes this gene non-functional are known to have low levels of LDL cholesterol and triglycerides, a low risk of heart disease, and no apparent health problems. The aim of this clinical trial was to artificially recreate the state in which this gene's activity is naturally stopped.
mui Lab unveils its first "Spatial AI" service for a well-being sleep experience at CES 2026
mui Lab Inc. will debut its "mui Calm Sleep Platform" at CES 2026, the first "Spatial AI" service designed for a well-being sleep experience. This platform eliminates the need for wearables or smartphone interaction; a natural wood smart home controller, the "mui Board," uses millimeter-wave radar to measure sleep states and provides personalized stretch guides and lighting adjustments based on the user's physical and mental condition. Developed under the supervision of a sleep specialist, this new healthcare approach supports sleep as something to be "nurtured" rather than "managed," without undue pressure from data.
Medicinal plant stem cells: A promising frontier in the genomics era
According to an article in "Engineering," medicinal plant stem cells are gaining attention as a transformative resource in the pharmaceutical, biotechnology, and cosmetic industries. These undifferentiated cells possess self-renewal and differentiation capabilities, crucial for plant growth, development, and regeneration. In agriculture, they enhance plant regeneration and stress tolerance, while in cosmetics, their antioxidant and regenerative properties are utilized in anti-aging products. In medicine, they enable sustainable drug production, offering an eco-friendly alternative to traditional plant extraction methods. Advancements in genomics, spatial omics, and CRISPR technology are expected to expand their future applications.
Nanosensor Technology Using Single-Walled Carbon Nanotubes Expected Applications in Enzyme Evaluation and Screening
Zymosense is a company developing new nanobiosensing technology for fast and simple enzyme activity measurement. Its core Nanoassay™ platform is based on nanosensor technology using single-walled carbon nanotubes (SWCNTs), detecting changes in near-infrared (NIR) emission accompanying enzyme reactions in real time. A key feature is its elimination of reaction termination and labeled reagents required in conventional enzyme assays, enabling a simple “dilute, add, measure” workflow. Its label-free and highly sensitive measurement capability makes it suitable not only for laboratory use but also for rapid on-site analysis. Applications are anticipated for enzyme evaluation and screening across diverse fields including food, pharmaceuticals, and biofuels.
Human clinical trial discovers Fasting Mimicking Diet improved autophagy
The trial demonstrated that FMD can enhance autophagy and improve metabolic health indicators in humans, including insulin sensitivity and fasting glucose levels.
Conducted by Cedars-Sinai and UT Health San Antonio, the study involved 30 healthy adults randomized to FMD or a normal diet.
FMD offers a nutrition-based intervention that mimics fasting benefits, potentially supporting healthy aging and longevity without the risks of extreme fasting.
The study provides evidence linking FMD to cellular recycling systems, marking a significant step in longevity science and nutrition technology.
New soft armband uses AI to read gestures while you run
A soft patch on the arm could soon let you steer robots with simple hand movements, even while your whole body is in motion. That is the promise of a new wearable system from engineers at the University of California San Diego, who set out to fix a problem that has held gesture control back for years.
Developed proprietary AI to identify beer flavor components Efficiently and comprehensively pinpoint key components influencing deliciousness (sensory evaluation)
Kirin Holdings Co., Ltd. (President and COO: Takeshi Minakata) has developed “FJWLA/Fujiwara (Flavor Judgment for Whole Liking Analysis),” a preference AI system that efficiently and comprehensively identifies key components influencing the deliciousness perceived by customers (sensory evaluation). This technology will be progressively introduced starting with beer products launched after March 2026, accelerating the advancement of flavor development and value creation.